1. The nitric oxide donor molsidomine rescues cardiac function in rats with chronic kidney disease and cardiac dysfunction
- Author
-
Bongartz, Lennart G., Braam, Branko, Verhaar, Marianne C., Cramer, Maarten Jan M., Goldschmeding, Roel, Gaillard, Carlo A., Steendijk, Paul, Doevendans, Pieter A., and Joles, Jaap A.
- Subjects
Chronic kidney failure -- Physiological aspects ,Chronic kidney failure -- Drug therapy ,Nitric oxide -- Health aspects ,Vasodilators -- Dosage and administration ,Heart diseases -- Physiological aspects ,Heart diseases -- Drug therapy ,Biological sciences - Abstract
We recently developed a rat model of cardiorenal failure that is characterized by severe left ventricular systolic dysfunction (LVSD) and low nitric oxide (NO) production that persisted after temporary low-dose NO synthase inhibition. We hypothesized that LVSD was due to continued low NO availability and might be reversed by supplementing NO. Rats underwent a subtotal nephrectomy and were treated with low-dose NO synthase inhibition with [N.sup.[omega]]-nitro-L-arginine up to week 8. After 3 wk of washout, rats were treated orally with either the long-acting, tolerance-free NO donor molsidomine (Mols) or vehicle (Veh). Cardiac and renal function were measured on weeks 11, 13, and 15. On week 16, LV hemodynamics and pressure-volume relationships were measured invasively, and rats were killed to quantify histological damage. On week 15, blood pressure was mildly reduced and creatinine clearance was increased by Mols (both P < 0.05). Mols treatment improved ejection fraction (53 [+ or -] 3% vs. 37 [+ or -] 2% in Veh-treated rats, P < 0.001) and stroke volume (324 [+ or -] 33 vs. 255 [+ or -] 15 [micro]l in Veh-treated rats, P < 0.05). Rats with Mols treatment had lower end-diastolic pressures (8.5 [+ or -] 1.1 mmHg) than Veh-treated rats (16.3 [+ or -] 3.5 mmHg, P < 0.05) and reduced time constants of relaxation (21.9 [+ or -] 1.8 vs. 30.9 [+ or -] 3.3 ms, respectively, P < 0.05). The LV end-systolic pressure-volume relationship was shifted to the left in Mols compared with Veh treatment. In summary, in a model of cardiorenal failure with low NO availability, supplementing NO significantly improves cardiac systolic and diastolic function without a major effect on afterload. left ventricular systolic dysfunction; rescue therapy; hemodynamics doi: 10.1152/ajpheart.00400.2010.
- Published
- 2010